An Essential ProviderA Quiet Innovator
We were the first in the world to develop ‘hot sensation plasters’ and ‘analgesic and anti-inflammatory plasters’.
Rather than looking to expand the scale of our company, Teikoku Seiyaku instead aims to be what we like to call a “quiet innovator”, in the sense that we use technology that is unique to us. In the context of being a “quiet innovator”, Teikoku Seiyaku is a pioneer in the field of anti-inflammatory and analgesic plasters, succeeding in developing the first hot sensation plaster containing anti-inflammatory and analgesic medication that is absorbed through the skin. Since the company’s foundation we have continued in this vein and the tradition continues with Lidoderm® as the first prescription plaster approved for the treatment of post-herpetic neuralgia (PHN) in the United States.
-
Hot sensation plaster *
(Approved in Japan on September 28, 1977) -
Indomethacin medicated plaster *
(Approved in Japan on March 29, 1988) -
Felbinac medicated plaster *
(Approved in Japan on July 2, 1993) -
Lidocaine medicated plaster **
(Approved in the U.S. on March 19, 1999)
* Original packaging * * Not sold in Japan